Thomas Moehler
Impact in
- Hematology top 0.5%
- Multiple Myeloma Research and Treatments
- Oncology top 5%
- Peptidase Inhibition and Analysis
- Cancer Treatment and Pharmacology
Papers in
- Hematology 58
- Multiple Myeloma Research and Treatments 57
-
- Protein Degradation and Inhibitors 10
- Glycosylation and Glycoproteins Research 7
- Cancer therapeutics and mechanisms 6
- Ubiquitin and proteasome pathways 4
- Co-authors
- Hartmut Goldschmidt (56 shared papers)Anthony D. Ho (28 shared papers)Kai Neben (20 shared papers)Jens Hillengaß (25 shared papers)Gerlinde Egerer (13 shared papers)Axel Benner (15 shared papers)Stefan Delorme (16 shared papers)Hans‐Ulrich Kauczor (8 shared papers)
- Journals
- Blood (13 papers)Recent results in cancer research (4 papers)Journal of Magnetic Resonance Imaging (3 papers)Clinical Cancer Research (3 papers)Annals of Hematology (3 papers)
- Partner nations
- GermanyFranceUnited States
In The Last Decade
Thomas Moehler
68 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 77
- Hematology 1.3k
- Oncology 624
- Genetics 205
- Emergency Medicine 129
- Orthopedics and Sports Medicine 119
Countries citing papers authored by Thomas Moehler
This map shows the geographic impact of Thomas Moehler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Moehler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Moehler more than expected).
Fields of papers citing papers by Thomas Moehler
This network shows the impact of papers produced by Thomas Moehler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Moehler. The network helps show where Thomas Moehler may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas Moehler, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 72 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 267 | |
| 2 | 2007 | 121 | |
| 3 | 1999 | 113 | |
| 4 | 2003 | 101 | |
| 5 | 2007 | 97 | |
| 6 | 2001 | 96 | |
| 7 | 2009 | 91 | |
| 8 | 1999 | 90 | |
| 9 | Dose-dependent effect of thalidomide on overall survival in relapsed multiple myeloma. | 2002 | 86 |
| 10 | 2005 | 80 | |
| 11 | 2002 | 69 | |
| 12 | 2007 | 67 | |
| 13 | 2001 | 63 | |
| 14 | High plasma basic fibroblast growth factor concentration is associated with response to thalidomide in progressive multiple myeloma. | 2001 | 58 |
| 15 | 2001 | 57 | |
| 16 | 2001 | 55 | |
| 17 | 2006 | 52 | |
| 18 | 2009 | 46 | |
| 19 | 2008 | 45 | |
| 20 | 2011 | 43 |
About Thomas Moehler
Thomas Moehler is a scholar working on Hematology, Molecular Biology, Oncology, Emergency Medicine and Orthopedics and Sports Medicine, having authored 72 papers that have together received 2.2k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (57 papers), Cancer Treatment and Pharmacology (14 papers), Protein Degradation and Inhibitors (10 papers), Glycosylation and Glycoproteins Research (7 papers), Hematological disorders and diagnostics (6 papers), Cancer therapeutics and mechanisms (6 papers), Bone and Joint Diseases (5 papers) and Ubiquitin and proteasome pathways (4 papers). The work is most often cited by research in Hematology (1.3k citations), Oncology (624 citations), Genetics (205 citations), Emergency Medicine (129 citations) and Orthopedics and Sports Medicine (119 citations). Thomas Moehler has collaborated with scholars based in Germany, France and United States. Frequent co-authors include Hartmut Goldschmidt, Anthony D. Ho, Kai Neben, Jens Hillengaß, Gerlinde Egerer, Axel Benner, Stefan Delorme, Hans‐Ulrich Kauczor, Alwin Kraemer and Dirk Hose. Their work appears in journals such as Blood, Recent results in cancer research, Journal of Magnetic Resonance Imaging, Clinical Cancer Research and Annals of Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.